Acute intermittent porphyria (AIP) is a rare metabolic disease involving a defect in haem biosynthesis resulting in the accumulation and excessive secretion of porphyrins and its precursors. Acute attacks present with episodes of severe abdominal pain, nausea, confusion and severe life-threatening seizures. A high index of suspicion is required for the initial diagnosis of AIP.
GursesCDurukanASencerS. A severe neurological sequela in acute intermittent porphyria: presentation of a case from encephalopathy to quadriparesis. Br J Radiol2008; 81: e135–e140.
4.
AndersonKEBloomerJRBonkovskyHL. Recommendations for the diagnosis and treatment of the acute porphyrias. Ann Intern Med2005; 142: 439–439.
5.
HarperPWahlinS. Treatment options in acute porphyria, porphyria cutanea tarda, and erythropoietic protoporphyria. Curr Treat Options Gastroenterol2007; 10: 444–444.
6.
WatsonCJ. Hematin and porphyria. N Eng J Med1975; 293: 605–607.
7.
KuoH-CLeeM-JChuangW-LHuangC-C. Acute intermittent porphyria with peripheral neuropathy: a follow-up study after hematin treatment. J Neurol Sci2007; 260: 231–235.
